Forum brings together governments, miners, investors and other critical stakeholders to shape the future of global mining RIYADH, Saudi Arabia, Jan. 7, 2022 /PRNewswire/ — As Saudi Arabia prepares to host one of the world’s Read more…
Daily Pivots: (S1) 156.12; (P) 156.79; (R1) 157.50; More… Intraday bias in GBP/JPY is turned neutral for consolidations first. Further rally is expected as long as 154.86 support holds. Decisive break of 158.19 high will Read more…
Daily Pivots: (S1) 130.55; (P) 130.99; (R1) 131.34; More…. Intraday bias in EUR/JPY is turned neutral for some consolidation. But further rally is in favor with 130.01 minor support intact. As noted before, whole consolidation from Read more…
Daily Pivots: (S1) 0.8330; (P) 0.8351; (R1) 0.8368; More… No change in EUR/GBP’s outlook as further decline is expected as long as 0.8417 resistance holds. Current fall is part of the larger down trend from Read more…
Daily Pivots: (S1) 1.5682; (P) 1.5752; (R1) 1.5844; More… Intraday bias remains neutral and outlook is unchanged in EUR/AUD. Further fall is expected as long as 1.5898 resistance holds. On the downside, break of 1.5559 Read more…
Daily Pivots: (S1) 1.0383; (P) 1.0398; (R1) 1.0424; More…. Intraday bias in EUR/CHF remains neutral for the moment. Outlook stays bearish as long as 1.0432 resistance holds. Break of 1.0324 will resume larger down trend Read more…
Daily Pivots: (S1) 1.2685; (P) 1.2749; (R1) 1.2792; More… Intraday bias in USD/CAD remains neutral and outlook is unchanged. As long as 1.2604 support holds, we’d still slightly favor another rally. Break of 1.2963 will Read more…
Daily Pivots: (S1) 0.7132; (P) 0.7177; (R1) 0.7209; More… Intraday bias in AUD/USD remains neutral for the moment. On the downside, break of 0.7081 support will indicate that corrective rebound from 0.6992 has completed with Read more…
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced new additions to the growing number of applications for QIAcuity, its ultrasensitive digital PCR (dPCR) platform that has set new standards by using so-called nanoplates Read more…
Montrouge, France, January 7, 2022 DBV Technologies to Present at the H.C. Wainwright BioConnect 2022 Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that Read more…